- Home
- STI vs DYAI Comparison
STI vs DYAI Comparison
Compare STI & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STI
- DYAI
- Stock Information
- Founded
- STI 2014
- DYAI 1979
- Country
- STI United States
- DYAI United States
- Employees
- STI N/A
- DYAI N/A
- Industry
- STI
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STI
- DYAI Health Care
- Exchange
- STI NYSE
- DYAI Nasdaq
- Market Cap
- STI 51.2M
- DYAI 54.4M
- IPO Year
- STI N/A
- DYAI 2004
- Fundamental
- Price
- STI $0.09
- DYAI $1.23
- Analyst Decision
- STI
- DYAI Strong Buy
- Analyst Count
- STI 0
- DYAI 1
- Target Price
- STI N/A
- DYAI $6.00
- AVG Volume (30 Days)
- STI 3.8M
- DYAI 31.1K
- Earning Date
- STI 06-06-2025
- DYAI 05-13-2025
- Dividend Yield
- STI N/A
- DYAI N/A
- EPS Growth
- STI N/A
- DYAI N/A
- EPS
- STI N/A
- DYAI N/A
- Revenue
- STI N/A
- DYAI $3,495,389.00
- Revenue This Year
- STI N/A
- DYAI $117.40
- Revenue Next Year
- STI N/A
- DYAI N/A
- P/E Ratio
- STI N/A
- DYAI N/A
- Revenue Growth
- STI 32.73
- DYAI 20.58
- 52 Week Low
- STI $0.08
- DYAI $0.93
- 52 Week High
- STI $3.25
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- STI 36.91
- DYAI 40.54
- Support Level
- STI $0.08
- DYAI $1.20
- Resistance Level
- STI $0.17
- DYAI $1.28
- Average True Range (ATR)
- STI 0.02
- DYAI 0.07
- MACD
- STI 0.01
- DYAI -0.00
- Stochastic Oscillator
- STI 20.65
- DYAI 25.93
About STI SOLIDION TECHNOLOGY INC
Solidion Technology Inc is engaged in researching, developing and manufacturing battery materials and components, as well as the development and production of next-generation batteries for energy storage systems and electric vehicles for ground, air, and sea transportation. It is recognized as a global IP leader in both the high-capacity anode and the high-energy solid-state battery.
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.